Cuilan Li/LinkedIn
Nov 19, 2025, 15:56
Cuilan Li on her Contribution to a Cutting-Edge Project in Polycythemia Vera
Cuilan Li, Founder and CEO at You First Consulting, shared on LinkedIn:
”Today I had the chance to contribute my expertise in hematology and oncology to a cutting-edge project in Polycythemia Vera (PV).
It was insightful, forward-thinking, and a powerful reminder of how real-world clinical insights empower the next wave of pharmaceutical and technology-driven innovation.
Proud to support projects that move science forward and strengthen clinical excellence.”
Stay updated with Hemostasis Today.
-
Jul 7, 2026, 20:59William Aird: An Unlucky Turn Into the Renal Artery
-
Jul 7, 2026, 20:58Chokri Ben Lamine: The Two-Hit Model of TRALI
-
Jul 7, 2026, 20:57New Issue of Blood Out Now – Blood Journals Portfolio
-
Jul 7, 2026, 20:56Priyadarshini Ramakrishnan: Schistocytes – The Most “Misleading Heroes” in a Peripheral Smear
-
Jul 7, 2026, 20:55Natasa Blagojevic-Stokic: Exploring the Role of ATP and Calcium Homeostasis in Autism
-
Jul 7, 2026, 17:49Alan Nurden: Safer Antithrombotic Therapy Through GPVI
-
Jul 7, 2026, 17:29Anticoagulation Reversal in 2026: Are We Winning the Bleeding Battle? – Francisco Chacón-Lozsán
-
Jul 7, 2026, 17:25Jim Hoffman: Targeting NETosis to Restore Immune Homeostasis
-
Jul 7, 2026, 17:14Shabneez Hussain: Blood Transfusion Professionals Connecting at ISBT 2026